Drugs Made In America Acquisition II Corp. (DMIIU) Payables (2024 - 2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Payables of $99359.0 for Q4 2025, down 60.27% year-over-year from $250100.0 in Q4 2024, and up 2063.74% quarter-over-quarter from $4592.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Payables for 2 consecutive years, with $99359.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 60.27% year-over-year to $99359.0; the TTM figure through Dec 2025 stood at $99359.0 (down 60.27% YoY), while the FY2025 annual figure was $99359.0, down 60.27% from the prior year.
- Payables advanced to $99359.0 in Q4 2025 per DMIIU's latest filing, from $4592.0 in the prior quarter.
- Across five years, Payables topped out at $250100.0 in Q4 2024 and bottomed at $4592.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,359.00 |
| Sep 30, 2025 | 4,592.00 |
| Dec 31, 2024 | 250,100.00 |